Drug · DIN 02487144
LIBTAYO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 7, 2025; first marketed May 24, 2019.
- Drug Identification Number (DIN)
- 02487144
- Company (DIN owner)
- Regeneron Canada CompanyMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Cemiplimab L01FF06
- Class
- Human
- Record last updated
- July 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEMIPLIMAB | 350 MG | 7 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 11, 2024: NOC 33433New Drug Submission (NDS) · Administrative - Change in Product Ownership
- April 10, 2019: NOC 22053New Drug Submission (NDS)
Other DINs named LIBTAYO
- DIN 02487152 · Cancelled Post Market